US Patent 10864194 Methods for treating heterotopic ossification
Patent 10864194 was granted and assigned to Clementia Pharmaceuticals on December, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10864194 Methods for treating heterotopic ossification
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
